Breast development is a key feature of feminization and therefore important to transwomen male-to-female transgender persons. It is not exactly known when breast development starts after initiating cross-sex hormone therapy CHT and how much growth may be expected. To investigate breast development in transwomen during their first year of CHT and whether clinical or laboratory parameters predict breast development.
Searchable abstracts of presentations at key conferences in endocrinology. Background: In male to female transgender patients breast development is a key part in the process of feminization using cross sex hormone therapy. But how much growth, in centimeters or cup-sizes, we can expect is not clear.
Transitioning refers to any physical, mental, or emotional change that a person makes in order to better reflect their gender identity. Some transgender people identify as neither male nor female, or as a combination of male and female. Everyone—transgender or not—has a gender identity.
Reuters Health - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests. For this type of transition, hormone therapy consists of both anti-androgens to block the activity of male sex hormones and curb male characteristics as well as estrogens to encourage breast development and feminization. Only 21 of the trans women attained a bra size of an A cup or larger after one year of hormone therapy, the study found. To assess breast growth, researchers measured the circumference of the chest underneath the breasts and at the largest part of the breasts.
Collage by Michelle Thompson. Recommendations on finding them are forthcoming. Not all transgender people transition, and transitions look different for all kinds of people.
Transgender hormone therapy of the male-to-female MTF type, also known as feminizing hormone therapyis hormone therapy and sex reassignment therapy to change the secondary sexual characteristics of transgender people from masculine or androgynous to feminine. Some intersex people also take this form of therapy, according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sexsuch as breasts and a feminine pattern of hairfatand muscle distribution.
Transgender women — people who are born with male genitalia but who identify with the female gender — who take feminizing hormone therapy have a higher risk of breast cancer compared to the average man, according to a Dutch study. The results also found that transgender men — people who are born with female genitalia but who identify with the male gender — who take masculine hormones have a lower risk of breast cancer than the average woman. The research was published online on May 14,by the journal BMJ.
I decided to come out to my family and friends as transgender at At the time I didn't really know what impact that decision would have on my life, but I knew I'd been in the wrong body for as long as I could remember. I didn't quite have the words to articulate my feelings until I found a YouTube of someone transitioning.
I have been asked to update my previous post about breast development. A few more pieces of the basic biology are now available. There have been some big changes about getting hormone therapy HT for breast development from providers.